Trademark: 97594202
Word
ARNATAR THERAPEUTICS CURE FOR CAUSE
Status Date
Tuesday, November 21, 2023
Filing Date
Friday, September 16, 2022
Published for Opposition
Tuesday, September 26, 2023
5 Medicines, namely, medical preparations for preventing or treating cardiovascular and metabolic diseases, as well as rare genetic diseases
The mark consists of the literal elements "ARNATAR THERAPEUTICS" represented in stylized font, and a design consisting of the graphic representation of a DNA helix superimposed diagonally across an incomplete circular ring wherein the design is located to the left of the wording, and wherein further, "ARNATAR" is located above "THERAPEUTICS".
The name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.
Color is not claimed as a feature of the mark.
The wording "ARNATAR" has no meaning in a foreign language.
"THERAPEUTICS"
Dec 23, 2023
Corrected Noa E-Mailed
Dec 22, 2023
Changes/Corrections After Pub Approval Entered
Dec 20, 2023
Assigned To Petition Staff
Nov 21, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 16, 2023
Teas Post Publication Amendment Received
Sep 26, 2023
Official Gazette Publication Confirmation E-Mailed
Sep 26, 2023
Published For Opposition
Sep 6, 2023
Notification Of Notice Of Publication E-Mailed
Aug 17, 2023
Approved For Pub - Principal Register
Aug 16, 2023
Teas/Email Correspondence Entered
Aug 15, 2023
Correspondence Received In Law Office
Aug 15, 2023
Teas Response To Office Action Received
Jun 29, 2023
Notification Of Non-Final Action E-Mailed
Jun 29, 2023
Non-Final Action E-Mailed
Jun 29, 2023
Non-Final Action Written
Jun 28, 2023
Assigned To Examiner
Oct 5, 2022
Notice Of Design Search Code E-Mailed
Oct 4, 2022
New Application Office Supplied Data Entered
Sep 20, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
